Company intelligence / Profile preview
BetterLife Pharma Inc.
- Ownership
- Private
- Development stage
- Other
Overview
BetterLife is currently conducting IND-enabling studies for its lead compounds. The cardio-pulmonary GLP studies for BETR-001 have been completed, and metabolism and genotoxicity GLP studies are to be initiated soon[5].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- Small moleculesNon-hallucinogenic psychedelic compounds
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on BetterLife Pharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BetterLife Pharma Inc..